Browse our TNFSF12 (TNFSF12) ELISA Kits

Full name:
Tumor Necrosis Factor (Ligand) Superfamily, Member 12 ELISA Kits (TNFSF12)
On www.antibodies-online.com are 32 Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12) ELISA Kits from 15 different suppliers available. Additionally we are shipping TNFSF12 Antibodies (145) and TNFSF12 Proteins (32) and many more products for this protein. A total of 218 TNFSF12 products are currently listed.
Synonyms:
Apo3l, Dr3l, Dr3lg, Tweak
list all ELISA KIts Gene Name GeneID UniProt
TNFSF12 8742 O43508
TNFSF12 21944 O54907
TNFSF12 360548  

Show all species

Show all synonyms

TNFSF12 (TNFSF12) ELISA Kits by Reactivity

Select your species

Top referenced TNFSF12 ELISA Kits

  1. Rat (Rattus) TNFSF12 ELISA Kit for Sandwich ELISA - ABIN1889352 : Chicheportiche, Bourdon, Xu, Hsu, Scott, Hession, Garcia, Browning: TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. in The Journal of biological chemistry 1998 (PubMed)

More ELISA Kits for TNFSF12 Interaction Partners

Human Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12) interaction partners

  1. Plasma TWEAK levels do not reflect disease activity or the grade of inflammation in patients with newly diagnosed inflammatory bowel disease.

  2. TWEAK may contribute to the pathogenesis of BP by reducing BP180 (show COL17A1 ELISA Kits) expression and cellular adherence, involving the activation of ERK (show EPHB2 ELISA Kits) and NF-kappaB (show NFKB1 ELISA Kits) pathways. TWEAK may serve as a biomarker or therapeutic target of BP.

  3. TWEAK upregulated the expression of Fn14 (show TNFRSF12A ELISA Kits).

  4. Fn14 (show TNFRSF12A ELISA Kits) plays a protective role during the acute stages of intestinal inflammation, and its absence promotes the development of colitis-associated cancer.

  5. Fn14 (show TNFRSF12A ELISA Kits).TRAIL can be converted into a highly effective TRAIL oligomer upon binding to TWEAK which induces lymphoblast apoptosis.

  6. Data show that aurintricarboxylic acid (ATA) targets the TNF-related WEAK inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (show DDX3X ELISA Kits) (Fn14 (show TNFRSF12A ELISA Kits)) signaling axis, which could potentially be developed as a new therapeutic agent for treatment of glioblastoma (GBM) patients.

  7. soluble Fn14 (show TNFRSF12A ELISA Kits) may serve as a potential biomarker for both acute and chronic kidney diseases.

  8. The result of transwell assay revealed that TWEAK promoted LX-2 migration. Subsequently, our data testified that the expression and activity of MMP9 (show MMP9 ELISA Kits) was induced by TWEAK in LX-2 cells, which enhanced the migration. Furthermore, our findings showed that TWEAK upregulated the phosphorylation of IkappaBalpha (show NFKBIA ELISA Kits) and p65 (show GORASP1 ELISA Kits) protein to increase MMP9 (show MMP9 ELISA Kits) expression in LX-2 cells.

  9. In this review article, we summarize studies indicating that (i) Fn14 (show TNFRSF12A ELISA Kits) gene expression is low in normal brain tissue but is upregulated in advanced brain cancers and, in particular, in GB tumors ; TWEAK: Fn14 (show TNFRSF12A ELISA Kits) engagement as well as Fn14 (show TNFRSF12A ELISA Kits) overexpression can stimulate glioma cell migration, invasion and resistance to chemotherapeutic agents in vitro.

  10. Findings suggest that TWEAK may contribute to chronic renal changes and renal fibrosis by activating TGF-beta1 (show TGFB1 ELISA Kits) signaling pathway, and phosphorylation of Smad2 (show SMAD2 ELISA Kits) and p38 MAPK (show MAPK14 ELISA Kits) proteins was also involved in this signaling pathway.

Mouse (Murine) Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12) interaction partners

  1. These results implicate TWEAK as a potential molecular target for treatment or prevention of inflammatory arthritis and autoimmune diseases such as rheumatoid arthritis.

  2. soluble Fn14 (show TNFRSF12A ELISA Kits) may serve as a potential biomarker for both acute and chronic kidney diseases.

  3. Findings suggest that TWEAK may contribute to chronic renal changes and renal fibrosis by activating TGF-beta1 (show TGFB1 ELISA Kits) signaling pathway, and phosphorylation of Smad2 (show SMAD2 ELISA Kits) and p38 MAPK (show MAPK14 ELISA Kits) proteins was also involved in this signaling pathway.

  4. TWEAK/Fn14 (show TNFRSF12A ELISA Kits) signaling represses PGC-1alpha (show PPARGC1A ELISA Kits) expression during acute kidney injury through activation of canonical NF-kappaB (show NFKB1 ELISA Kits) pathways and epigenetic mechanisms including histone deacetylation on NF-kappaB (show NFKB1 ELISA Kits)-binding sites.

  5. These findings suggest that TWEAK signaling might be an aspect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine -mediated neuropathology and be involved in the overall neurodegenerative pathology of Parkinson's disease

  6. results revealed that TWEAK and Fn14 (show TNFRSF12A ELISA Kits) are expressed by uterine natural killer cells in pregnant mice

  7. studies show that signaling via TWEAK is deleterious to muscle in RNA toxicity and support the demonstrated utility of anti-TWEAK therapeutics.

  8. During ischaemia, soluble CD163 (show CD163 ELISA Kits) functions as a decoy receptor for TWEAK, to regulate TWEAK-induced activation of canonical nuclear factor-kappaB and Notch (show NOTCH1 ELISA Kits) signalling necessary for myogenic progenitor cell proliferation.

  9. TWEAK/Fn14 (show TNFRSF12A ELISA Kits) interactions play an important role in the pathogenesis of neuropsychiatric lupus by increasing the accumulation of inflammatory cells in the choroid plexus, disrupting blood brain barrier integrity, and increasing neuronal damage

  10. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis

TNFSF12 Antigen Profile

Antigen Summary

The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. This cytokine, which exists in both membrane-bound and secreted forms, can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Alternative splicing results in multiple transcript variants. Some transcripts skip the last exon of this gene and continue into the second exon of the neighboring TNFSF13 gene\; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13.

Alternative names and synonyms associated with TNFSF12

  • tumor necrosis factor (ligand) superfamily, member 12 (TNFSF12) Elisa Kit
  • tumor necrosis factor (ligand) superfamily, member 12 (Tnfsf12) Elisa Kit
  • tumor necrosis factor ligand superfamily member 12 (Tnfsf12) Elisa Kit
  • Apo3l Elisa Kit
  • Dr3l Elisa Kit
  • Dr3lg Elisa Kit
  • Tweak Elisa Kit

Protein level used designations for TNFSF12

APO3 ligand , APO3/DR3 ligand , TNF-related WEAK inducer of apoptosis , tumor necrosis factor ligand superfamily member 12 , tumor necrosis factor superfamily member 12 , TNF-related weak inducer of apoptosis

GENE ID SPECIES
8742 Homo sapiens
100568280 Canis lupus familiaris
21944 Mus musculus
360548 Rattus norvegicus
Selected quality suppliers for TNFSF12 (TNFSF12) ELISA Kits
Did you look for something else?